Global

‡ In these countries please contact our distributor

I - Infection

Using the Smith & Nephew T.I.M.E. assessment tool to choose treatment for wound infection and inflammation.
The products used in the T.I.M.E. clinical decision support tool may vary in different markets.  Not all products referred to may be approved for use or available in all markets.  Please consult your local Smith & Nephew representative for further details on products available in your market.
Intended for healthcare professionals outside of the US only.

 

Aim to achieve non-inflamed, non-infected wounds

Identifying and addressing wound infection, to reduce bacterial burden and dampen the inflammatory response, is essential to promote wound healing and correctly inform antibiotics use1.

 

When to act on infection2

 

 

Think – Contamination: unless compromised, patient will respond and destroy bacteria.
Think – Colonisation: limited, non-critical proliferation of microbes that will not affect wound progression.
Act – Localised: deeper presence in the wound tissue, but currently contained in one location, system or structure.
Act – Spreading: infection present in surrounding tissue with signs and symptoms beyond the wound border, potentially into deep tissue, muscle, fascia organs or body cavities.
Act – Systemic: microorganisms spread through the vascular or lymphatic systems and can affect the whole body.

 

  Disrupt: Biofilm occurs in 78% of wounds, causing constant inflammation, delayed healing and treatment failure. Effective assessment and identification is essential to initiate the correct treatment3-4.

 

 

The invisible is now visible

Use the MolecuLight i:XTM device to visualise fluorescent bacteria which would not otherwise be possible within standard of care protocols5,6.

 

Using our T.I.M.E. clinical decision support tool

 

Infected: treat with an antimicrobial*

ACTICOAT Nanocrystalline Silver Dressings

 

 

Deeply infected cavity wound: treat with an antimicrobial*

DURAFIBER Ag Silver Gelling Fibre (SGF) dressing

 

 

Suspected biofilm: treat with an antimicrobial*

IODOFLEX Cadexomer Iodine Pad
IODOSORB Cadexomer Iodine Ointment, Gel or Powder

 

  Next step > Evaluate the effectiveness of treatment and progression towards your wound management goal.

 

For additional product information or ordering instructions, arrange a call from a Smith & Nephew representative.

 

Helping you get CLOSER TO ZERO delay in wound healing.

 

A healthcare professional must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Smith & Nephew does not dispense medical advice and recommends that healthcare professionals be trained in the use of any particular product before using it on patients.

 

For detailed product information, including indications for use, contraindications, effects, precautions, warnings, and important safety information, please consult the Instructions for Use (IFU) prior to use.

*Use appropriate secondary dressings according to your local protocol. View example dressings in the ALLEVYN or OPSITE ranges.

 

References

1) Schultz G, et al. (2005) Wound healing and T.I.M.E.; new concepts and scientific applications. Wound Repair Regen. 13, S1–11.
2) International Wound Infection Institute (IWII). Wound infection in clinical practice. Wounds International 2016.
3) Malone, M., Bjarnsholt, T., McBain, A.J. et al. The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data, J. Wound Care 2016; vol 25, no 12.
4) Schultz, G., Bjarnsholt, T., Garth A. James, G.A., Leaper, D.j., McBain, A.j. et al for the Global Wound Biofilm Expert Panel. Consensus guidelines for the identification and treatment of biofilms in chronic non-healing wounds.
5) DaCosta RS, Kulbatski I, Lindvere-Teene L, Starr D, Blackmore K, Silver JI, Opoku J, Wu YC, Medeiros PJ, Xu W, et al. Point-of-care autofluorescence imaging for real-time sampling and treatment guidance of bioburden in chronic wounds: first-in-human results. PLoS One. 2015 Mar 19;10(3).
6) Raizman R. Point-of-care fluorescence imaging device guides care and patient education in obese patients with surgical site infections. Presented at: CAWC 2016. Proceedings of the 22nd Annual Canadian Association of Wound Care Conference; 2016 Nov 3-6, Niagara Falls, ON. 

Download the T.I.M.E. clinical decision tool

Download now

 

The products used in the T.I.M.E. clinical decision support tool may vary in different markets.  Not all products referred to may be approved for use or available in all markets.  Please consult your local Smith & Nephew representative for further details on products available in your market.
Intended for healthcare professionals outside of the US only.